# Drug Development: Pathway for Approving Antibacterial and Antifungal Drugs for Patients with Limited Treatment Options is Infrequently Used
> **GAO Report** · 2021-11-19 · `gao-22-105042`
## Report
- **GAO ID:** gao-22-105042
- **Type:** Report
- **Published:** 2021-11-19
## Source
- [GAO product page](https://www.gao.gov/products/gao-22-105042)
---
*MORVS · CC0 1.0*